Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors
Microtubule (MT) inhibitors show anti-cancer activity in a wide range of tumors in vitro and demonstrate high clinical efficacy. To date they are routinely included into many chemotherapeutic regimens. While the mechanisms of MT inhibitors’ interactions with tubulin have been well-established, the r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00436/full |
| _version_ | 1818482226630754304 |
|---|---|
| author | Daria M. Potashnikova Daria M. Potashnikova Aleena A. Saidova Aleena A. Saidova Anna V. Tvorogova Anna V. Tvorogova Eugene V. Sheval Ivan A. Vorobjev Ivan A. Vorobjev Ivan A. Vorobjev |
| author_facet | Daria M. Potashnikova Daria M. Potashnikova Aleena A. Saidova Aleena A. Saidova Anna V. Tvorogova Anna V. Tvorogova Eugene V. Sheval Ivan A. Vorobjev Ivan A. Vorobjev Ivan A. Vorobjev |
| author_sort | Daria M. Potashnikova |
| collection | DOAJ |
| description | Microtubule (MT) inhibitors show anti-cancer activity in a wide range of tumors in vitro and demonstrate high clinical efficacy. To date they are routinely included into many chemotherapeutic regimens. While the mechanisms of MT inhibitors’ interactions with tubulin have been well-established, the relationship between their concentration and effect on neoplastic cells is not completely understood. The common notion is that tumor cells are most vulnerable during division and all MT inhibitors block them in mitosis and induce mitotic checkpoint-associated cell death. At the same time multiple evidence of more subtle effects of lower doses of MT inhibitors on cell physiology exist. The extent of efficacy of the low-dose MT inhibitor treatment and the mechanisms of resulting cell death currently present a critical issue in oncology. The prospect of MT inhibitor dose reduction is promising as protocols at higher concentration have multiple side effects. We assessed cell cycle changes and cell death induced by MT inhibitors (paclitaxel, nocodazole, and vinorelbine) on human lymphoid B-cell lines in a broad concentration range. All inhibitors had similar accumulation effects and demonstrated “trigger” concentrations that induce cell accumulation in G2/M phase. Concentrations slightly below the “trigger” promoted cell accumulation in sub-G1 phase. Multi-label analysis of live cells showed that the sub-G1 population is heterogeneous and may include cells that are still viable after 24 h of treatment. Effects observed were similar for cells expressing Tat-protein. Thus cell cycle progression and cell death are differentially affected by high and low MT inhibitor concentrations. |
| first_indexed | 2024-12-10T11:44:57Z |
| format | Article |
| id | doaj.art-e91a2ad29f924696b2e13b9e17566644 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-10T11:44:57Z |
| publishDate | 2019-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-e91a2ad29f924696b2e13b9e175666442022-12-22T01:50:07ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-04-011010.3389/fphar.2019.00436453430Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule InhibitorsDaria M. Potashnikova0Daria M. Potashnikova1Aleena A. Saidova2Aleena A. Saidova3Anna V. Tvorogova4Anna V. Tvorogova5Eugene V. Sheval6Ivan A. Vorobjev7Ivan A. Vorobjev8Ivan A. Vorobjev9Department of Cell Biology and Histology, School of Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaLaboratory of Atherothrombosis, Moscow State University of Medicine and Dentistry, Moscow, RussiaDepartment of Cell Biology and Histology, School of Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaDepartment of Cell Biotechnology, Center of Experimental Embryology and Reproductive Biotechnology, Moscow, RussiaDepartment of Cell Biotechnology, Center of Experimental Embryology and Reproductive Biotechnology, Moscow, RussiaA.N. Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaA.N. Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaDepartment of Cell Biology and Histology, School of Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaA.N. Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Moscow, RussiaDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, KazakhstanMicrotubule (MT) inhibitors show anti-cancer activity in a wide range of tumors in vitro and demonstrate high clinical efficacy. To date they are routinely included into many chemotherapeutic regimens. While the mechanisms of MT inhibitors’ interactions with tubulin have been well-established, the relationship between their concentration and effect on neoplastic cells is not completely understood. The common notion is that tumor cells are most vulnerable during division and all MT inhibitors block them in mitosis and induce mitotic checkpoint-associated cell death. At the same time multiple evidence of more subtle effects of lower doses of MT inhibitors on cell physiology exist. The extent of efficacy of the low-dose MT inhibitor treatment and the mechanisms of resulting cell death currently present a critical issue in oncology. The prospect of MT inhibitor dose reduction is promising as protocols at higher concentration have multiple side effects. We assessed cell cycle changes and cell death induced by MT inhibitors (paclitaxel, nocodazole, and vinorelbine) on human lymphoid B-cell lines in a broad concentration range. All inhibitors had similar accumulation effects and demonstrated “trigger” concentrations that induce cell accumulation in G2/M phase. Concentrations slightly below the “trigger” promoted cell accumulation in sub-G1 phase. Multi-label analysis of live cells showed that the sub-G1 population is heterogeneous and may include cells that are still viable after 24 h of treatment. Effects observed were similar for cells expressing Tat-protein. Thus cell cycle progression and cell death are differentially affected by high and low MT inhibitor concentrations.https://www.frontiersin.org/article/10.3389/fphar.2019.00436/fullcell cyclecell deathmicrotubule inhibitorspaclitaxelnocodazolevinorelbine |
| spellingShingle | Daria M. Potashnikova Daria M. Potashnikova Aleena A. Saidova Aleena A. Saidova Anna V. Tvorogova Anna V. Tvorogova Eugene V. Sheval Ivan A. Vorobjev Ivan A. Vorobjev Ivan A. Vorobjev Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors Frontiers in Pharmacology cell cycle cell death microtubule inhibitors paclitaxel nocodazole vinorelbine |
| title | Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors |
| title_full | Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors |
| title_fullStr | Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors |
| title_full_unstemmed | Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors |
| title_short | Non-linear Dose Response of Lymphocyte Cell Lines to Microtubule Inhibitors |
| title_sort | non linear dose response of lymphocyte cell lines to microtubule inhibitors |
| topic | cell cycle cell death microtubule inhibitors paclitaxel nocodazole vinorelbine |
| url | https://www.frontiersin.org/article/10.3389/fphar.2019.00436/full |
| work_keys_str_mv | AT dariampotashnikova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT dariampotashnikova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT aleenaasaidova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT aleenaasaidova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT annavtvorogova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT annavtvorogova nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT eugenevsheval nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT ivanavorobjev nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT ivanavorobjev nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors AT ivanavorobjev nonlineardoseresponseoflymphocytecelllinestomicrotubuleinhibitors |